Physician profile
Ronald M Angles
NPI 1245284918
$2,356.33
in general payments reported to CMS, 2019-2025
13 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956 · 2020: $241 · 2021: $475 · 2022: $351 · 2023: $210 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,360.82 | 2019-2023 | Exalt Model D |
| Steris Corporation | $240.93 | 2022 | |
| Phathom Pharmaceuticals, INC. | $122.17 | 2025 | Voquezna |
| Conmed Corporation | $107.56 | 2021 | |
| Pfizer INC. | $90.56 | 2019-2020 | |
| Cook Medical LLC | $86.78 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.29 | 2019-2020 | |
| Covidien Lp | $75.10 | 2020 | |
| Micro-Tech Endoscopy USA, INC. | $60.60 | 2021 | |
| Ironwood Pharmaceuticals, INC | $53.17 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.00 | 2019 | |
| Daiichi Sankyo INC. | $23.43 | 2022 | |
| Abbvie INC. | $14.92 | 2023 | Rinvoq, Skyrizi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Angles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.